Your browser doesn't support javascript.
loading
CD30+OX40+ Treg is associated with improved overall survival in colorectal cancer.
Lam, Jian Hang; Hong, Michelle; Koo, Si-Lin; Chua, Clarinda Wei Ling; Lim, Kah Ling; Wee, Felicia; Wan, Wei Keat; Leow, Wei Qiang; Yeo, Joo Guan; Tan, Iain Bee Huat; Yeong, Joe; Lim, Tony Kiat Hon; Lim, Tong Seng.
Afiliação
  • Lam JH; A. Menarini Biomarkers Singapore Pte Ltd, Singapore, Singapore.
  • Hong M; A. Menarini Biomarkers Singapore Pte Ltd, Singapore, Singapore.
  • Koo SL; Division of Medical Oncology, National Cancer Centre, Singapore, Singapore.
  • Chua CWL; Division of Medical Oncology, National Cancer Centre, Singapore, Singapore.
  • Lim KL; Division of Pathology, Singapore General Hospital, Singapore, Singapore.
  • Wee F; Division of Pathology, Singapore General Hospital, Singapore, Singapore.
  • Wan WK; Division of Pathology, Singapore General Hospital, Singapore, Singapore.
  • Leow WQ; Division of Pathology, Singapore General Hospital, Singapore, Singapore.
  • Yeo JG; Translational Immunology Institute, SingHealth Duke-NUS Academic Medical Centre, Singapore, Singapore.
  • Tan IBH; Division of Medical Oncology, National Cancer Centre, Singapore, Singapore.
  • Yeong J; Division of Pathology, Singapore General Hospital, Singapore, Singapore. Joe.yeong.p.s@sgh.com.sg.
  • Lim TKH; Institute of Molecular Cell Biology (IMCB), Agency of Science, Technology and Research (A*STAR), Singapore, Singapore. Joe.yeong.p.s@sgh.com.sg.
  • Lim TS; Division of Pathology, Singapore General Hospital, Singapore, Singapore. lim.kiat.hon@singhealth.com.sg.
Cancer Immunol Immunother ; 70(8): 2353-2365, 2021 Aug.
Article em En | MEDLINE | ID: mdl-33527196

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Linfócitos T Reguladores / Antígeno Ki-1 / Receptores OX40 Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Cancer Immunol Immunother Assunto da revista: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Singapura País de publicação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Linfócitos T Reguladores / Antígeno Ki-1 / Receptores OX40 Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Cancer Immunol Immunother Assunto da revista: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Singapura País de publicação: Alemanha